New Zealand markets closed

Moderna, Inc. (MRNA)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
164.01+0.68 (+0.42%)
At close: 04:00PM EDT
163.37 -0.64 (-0.39%)
Pre-market: 06:45AM EDT
Full screen
Trade prices are not sourced from all markets
Previous close163.33
Bid163.99 x 200
Ask164.09 x 200
Day's range157.46 - 165.14
52-week range62.55 - 165.14
Avg. volume3,913,992
Market cap62.855B
Beta (5Y monthly)1.57
PE ratio (TTM)N/A
EPS (TTM)-15.60
Earnings date01 Aug 2024 - 05 Aug 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est137.59
  • Zacks

    Vaccine Stocks Rise on Growing Threat of Bird Flu Infections

    The Biden administration is reportedly in talks with vaccine makers Moderna (MRNA) and Pfizer (PFE) to develop bird flu vaccines over increasing fears of widespread transmission of the infection.

  • Bloomberg

    Second US Human Bird Flu Infection Reported in Michigan

    (Bloomberg) -- A Michigan farmworker tested positive with bird flu, the second person to contract the potentially lethal virus that has run rampant in US cattle.Most Read from BloombergNvidia Stock Surges as Sales Forecast Delivers on AI HopesThese Flight Routes Suffer the World’s Worst TurbulenceCiti Trader Got 711 Warning Messages Before Sparking Flash CrashHarvard Defies Faculty Vote to Block 13 Students From GraduatingUS Justice Department to Seek Breakup of Live Nation-TicketmasterThe farmw


    Moderna and Pfizer In Talks With U.S. To Make a Bird Flu Vaccine

    Last year, Moderna began early-stage tests of a number of avian flu vaccines that target different strains of the virus.